NCT05348226View on ClinicalTrials.gov

The ENVI Study: Effect of Entresto on Left Ventricular Remodelling on Cardiac MRI

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

June 9, 2021

Primary Completion Date

March 23, 2023

Study Completion Date

March 23, 2023

Conditions
Heart Failure With Reduced Ejection Fraction
Interventions
DIAGNOSTIC_TEST

Additional Cardiac Magnetic Resonance Scan

Standard of care medical treatment with sacubitril/valsartan (Entresto). Additional Cardiac Magnetic Resonance Imaging (CMR) Scan after 4-6 months of treatment.

Trial Locations (1)

SO16 6YD

University Hospital Southampton NHS Foundation Trust, Southampton

All Listed Sponsors
lead

University Hospital Southampton NHS Foundation Trust

OTHER